Influence of size of regions of interest on the measurement of uptake of 123I-α-methyl tyrosine by brain tumours

Nuclear Medicine Communications

Volumn 17, Issue 7, 1996, Pages 609-615

  Kuwert, T ^a   Morgenroth, C ^b   Woesler, B ^b   Matheja, P ^a   Palkovic, S ^b   Vollet, B ^a   Schafers M ^a   Wassmann, H ^b  

^a Departments of Nuclear Medicine   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA METHYLTYROSINE I 123; IODINE 123; TYROSINE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLIOMA; HUMAN; MALE; METABOLISM; OLIGODENDROGLIOMA; QUANTITATIVE DIAGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUBEPENDYMOMA;

EID: 0029793851     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199607000-00012     Document Type: Article

References (28)

1. Herholz K. Tracers for clinical evaluation of gliomas: A neurologist's view. In: Mazoyer BM, Heiss WD, Comar D, eds. PET studies on amino acid metabolism and protein systhesis. Dordrecht: Kluwer Academic, 1993: 203-214.
2. Leeds NE, Jackson EF. Current imaging techniques for the evaluation of brain neoplasms. Curr Opin Oncol 1994: 6: 254-261.
3. Conti PS. Introduction to imaging brain tumour metabolism with positron emission tomography. Cancer Invest 1995; 13: 244-259.
4. 123I- α-methyl tyrosine as a SPECT tracer of amino acid uptake in brain tumors. In: De Deyn PP, Dierckx RA, Pickut BA, eds. SPECT in neurology and psychiatry. London: Libbey (in press).
5. Kuwert T, Sures T, Herzog H et al. On the influence of spatial resolution and of the size and form of regions of interest on the measurement of regional cerebral metabolic rates by positron emission tomography. J Neural Transm 1992; 37 (suppL): 53-66.
6. Horwitz B. Quantification and analysis of positron emission tomography metabolic data. In: Duara R, ed. Positron emission tomography in dementia. New York: Wiley-Liss, 1990: 13-70.
7. Kuwert T, Ganslandt T, Jansen P et al. Influence of size of regions of interest on PET evaluation of caudate glucose consumption. J Comput Assist Tomogr 1992; 16: 789-794.
8. Zülch KJ. Principles of the new World Health Organization (WHO) classification. Neuroradiology 1980; 19: 59-66.
9. 3, a reagent for iodination with high specific activity. Radioclin Acta 1977; 24: 42-46.
10. Fischer S, Wolf H, Brandau W, Clausen M, Henze E, Schober O. Iodierung von α-Methyltyrosin (AMT): Optimierung der Methode für die Routinepräparation. Nucl Med 1993; 32: A113.
11. Kuikka JT, Tenhunen-Eskelinen M, Jurvelin J, Kilianen H. Physical performance of the Siemens Multi SPECT 3 gamma camera. Nucl Med Commun 1993; 13: 490-497.
12. Chang LT. A Method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sei (NS) 1978; 26: 2780-2789.
13. Bortz J. Lehrbuch der Statistik, 2nd edn. Berlin: SpringerVerlag, 1985.
14. Oriuchi N, Tamura M, Shibazaki T et al. Clinical evaluation of thallium-201 SPECT in supratentorial gliomas: Relationship to histologic grade, prognosis and proliferative activities. J Nucl Med 1993; 34: 2085-2089.
15. 124IMT. J Nucl Med 1990; 31: 281-286.
16. 18F-fluorodeoxyglucose PET. AJR, 1994; 163: 1459-1456.
17. Delbeke D, Meyerowitz C, Lapidus RL et al. Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET. Radiology 1995; 195: 47-52.
18. Ogawa T, Shishido F, Kanno, et al. Cerebral glioma: Evaluation with methionine PET. Radiology 1993; 186: 45-53.
19. Mineura K, Sasajima T, Kowada M et al. Perfusion and metabolism in predicting the survival of patients with cerebral gliomas. Cancer 1994; 73: 2386-2394.
20. 18F]fluorodeoxyglucose positron emission tomographicregion-of-interest data. J Cereb Blood Flow Metab 1991; 11: A83-A88.
21. Hoffman EJ, Huang SC, Phelps ME. Quantitation in positron emission computed tomography. I. Effect of object size. J Comput Assist Tomogr 1979; 3: 299-308.
22. Mazziotta JC, Phelps ME, Plummer D, Kuhl DE. Quantitation in positron emission computed tomography: IV. Physical-anatomical effects. J Comput Assist Tomogr 1981; 5: 734-743.
23. Paulus W. Tumoren des Zentralnervensystems. In: Pfeiffer J, Schröder JM, eds. Neuropathologie. Berlin: Springer-Verlag, 1995: 217-262.
24. Mosskin S, Ericson K, Hindmarsh T et al. Positron emission tomography compared with magnetic resonance imaging and computed tomography in supratentorial gliomas using multiple stereotactic biopsies as reference. Acta Radiol 1989; 30: 225-232.
25. Kuwert T, Morgenroth C, Woesler B et al. Uptake of iodine- 123-α-methyl tyrosine by primary brain tumors and nonneoplastic brain lesions (submitted).
26. nC]L-Methionine uptake in gliomas. Neurosurgery 1989; 30: 225-232.
27. Schober O, Meyer G-J, Stolke D, Hundeshagen H. Brain tumor imaging using C-ll-labelled L-methionine and D- methionine. J Nucl Med 1985; 26: 98-99.
28. Schober O, Meyer G-J, Duden C et al. Die Aufnahme von Aminosäuren in Hirntumoren mit der Positronenemissionstomographie als Indikator für die Beurteilung von Stoffwechselaktivität und Malignität. Fortshr Röntgenstr 1987; 147: 503-509.